EA201892254A1 - Экстракт табачного листа и его применение для лечения табачной зависимости - Google Patents

Экстракт табачного листа и его применение для лечения табачной зависимости

Info

Publication number
EA201892254A1
EA201892254A1 EA201892254A EA201892254A EA201892254A1 EA 201892254 A1 EA201892254 A1 EA 201892254A1 EA 201892254 A EA201892254 A EA 201892254A EA 201892254 A EA201892254 A EA 201892254A EA 201892254 A1 EA201892254 A1 EA 201892254A1
Authority
EA
Eurasian Patent Office
Prior art keywords
tobacco
extract
treatment
application
dependence
Prior art date
Application number
EA201892254A
Other languages
English (en)
Inventor
Брюно Лафон
Original Assignee
Нфл Биосайенсиз
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Нфл Биосайенсиз filed Critical Нфл Биосайенсиз
Publication of EA201892254A1 publication Critical patent/EA201892254A1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0021—Intradermal administration, e.g. through microneedle arrays, needleless injectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/10—Preparation or pretreatment of starting material
    • A61K2236/15—Preparation or pretreatment of starting material involving mechanical treatment, e.g. chopping up, cutting or grinding
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/50—Methods involving additional extraction steps
    • A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/50—Methods involving additional extraction steps
    • A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Addiction (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Botany (AREA)
  • Dermatology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Manufacture Of Tobacco Products (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Изобретение относится к экстракту табачного листа, содержащему, в пересчете на общую массу экстракта, по меньшей мере 5 мас.% белков, по существу, не содержащих молекул, молекулярная масса которых составляет менее 10 кДа. Изобретение также относится к фармацевтической композиции, содержащей такой экстракт, и к ее применению в лечении табачной зависимости.
EA201892254A 2016-04-07 2017-04-07 Экстракт табачного листа и его применение для лечения табачной зависимости EA201892254A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1653079A FR3049866B1 (fr) 2016-04-07 2016-04-07 Extrait de feuilles de tabac et utilisation pour le traitement de l'addiction au tabac
PCT/EP2017/058398 WO2017174787A1 (fr) 2016-04-07 2017-04-07 Extrait de feuilles de tabac et utilisation pour le traitement de l'addiction au tabac

Publications (1)

Publication Number Publication Date
EA201892254A1 true EA201892254A1 (ru) 2019-04-30

Family

ID=56101683

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201892254A EA201892254A1 (ru) 2016-04-07 2017-04-07 Экстракт табачного листа и его применение для лечения табачной зависимости

Country Status (20)

Country Link
US (2) US11123395B2 (ru)
EP (2) EP4285999A3 (ru)
JP (1) JP7206111B2 (ru)
KR (1) KR102408766B1 (ru)
CN (1) CN109195616B (ru)
AU (1) AU2017248103B2 (ru)
BR (1) BR112018070579B1 (ru)
CA (1) CA3020055A1 (ru)
DK (1) DK3439680T3 (ru)
EA (1) EA201892254A1 (ru)
ES (1) ES2971275T3 (ru)
FR (1) FR3049866B1 (ru)
IL (1) IL262145B (ru)
MX (1) MX2018012235A (ru)
PH (1) PH12018502138A1 (ru)
PL (1) PL3439680T3 (ru)
SA (1) SA518400176B1 (ru)
UA (1) UA126794C2 (ru)
WO (1) WO2017174787A1 (ru)
ZA (2) ZA201807436B (ru)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3049866B1 (fr) * 2016-04-07 2019-09-06 Nfl Biosciences Extrait de feuilles de tabac et utilisation pour le traitement de l'addiction au tabac
WO2024089465A2 (en) * 2022-10-24 2024-05-02 Nfl Biosciences Methods of treatment involving tobacco leaf extracts to help smoking cessation

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4941484A (en) * 1989-05-30 1990-07-17 R. J. Reynolds Tobacco Company Tobacco processing
DE122005000035I2 (de) * 1992-09-21 2008-03-27 Leti Lab Verfahren zur reinigung von waessrigen extrakten, die allergenische proteine enthalten, so erhaltene extrakte und ihre verwendung
IE960511A1 (en) 1996-07-15 1998-01-28 Michael Anthony Folan Nicotine-containing homeopathic dilution and its use in¹restoring neuronal function
US20050250736A1 (en) * 2004-05-10 2005-11-10 Michael Cherkassky Composition and method for treatment of obesity and smoking cessation
GB0425248D0 (en) * 2004-11-16 2004-12-15 Gw Pharma Ltd New use for cannabinoid
FR2900825B1 (fr) * 2006-05-09 2012-10-26 Jean Pierre Nicolas Extrait aqueux de feuilles de tabac, ses utilisations dans le traitement de la dependance
CN100574782C (zh) * 2007-06-18 2009-12-30 王伟成 含尼古丁水溶液在制备戒烟药物的应用
US7887821B2 (en) * 2007-12-20 2011-02-15 Alk-Abello A/S Process for producing an allergen extract
CN101569436A (zh) * 2008-04-28 2009-11-04 李复元 一种香烟型戒烟保健吸品
WO2011084376A1 (en) * 2009-12-21 2011-07-14 Rock Creek Pharmaceuticals, Inc. Smoking cessation lozenge containing tobacco alkaloid and silver salt
US9175052B2 (en) * 2013-05-17 2015-11-03 R.J. Reynolds Tobacco Company Tobacco-derived protein compositions
US20160177285A1 (en) * 2013-08-05 2016-06-23 Gerard Voerman Novel means to decrease the negative effects of smoking
CN104151140B (zh) * 2014-07-11 2016-01-06 武汉工程大学 一种从烟叶中综合提取多种有效成分的方法
FR3049866B1 (fr) * 2016-04-07 2019-09-06 Nfl Biosciences Extrait de feuilles de tabac et utilisation pour le traitement de l'addiction au tabac

Also Published As

Publication number Publication date
ES2971275T3 (es) 2024-06-04
EP3439680A1 (fr) 2019-02-13
EP3439680B1 (fr) 2023-11-22
US20190151393A1 (en) 2019-05-23
US11123395B2 (en) 2021-09-21
ZA201807436B (en) 2022-07-27
PL3439680T3 (pl) 2024-04-15
KR20180132835A (ko) 2018-12-12
MX2018012235A (es) 2019-03-28
UA126794C2 (uk) 2023-02-08
DK3439680T3 (da) 2024-02-12
JP2019511516A (ja) 2019-04-25
SA518400176B1 (ar) 2022-06-12
WO2017174787A1 (fr) 2017-10-12
BR112018070579A2 (pt) 2019-02-05
JP7206111B2 (ja) 2023-01-17
CN109195616A (zh) 2019-01-11
EP4285999A2 (fr) 2023-12-06
CA3020055A1 (fr) 2017-10-12
US11865156B2 (en) 2024-01-09
IL262145A (en) 2018-11-29
IL262145B (en) 2021-06-30
FR3049866B1 (fr) 2019-09-06
EP4285999A3 (fr) 2024-03-13
FR3049866A1 (fr) 2017-10-13
ZA202201610B (en) 2024-06-26
KR102408766B1 (ko) 2022-06-13
AU2017248103B2 (en) 2023-12-14
AU2017248103A1 (en) 2018-11-22
US20210401921A1 (en) 2021-12-30
PH12018502138A1 (en) 2019-09-23
CN109195616B (zh) 2022-06-07
BR112018070579B1 (pt) 2024-04-30

Similar Documents

Publication Publication Date Title
PH12020500500A1 (en) Pyrazolopyrimidinone compounds and uses thereof
EP4302834A3 (en) 2,5-disubstituted 3-methyl pyrazines and 2,5,6-trisubstituted 3-methyl pyrazines as allosteric shp2 inhibitors
EA201992878A1 (ru) Соединения для лечения болезни хантингтона
CY1125025T1 (el) 2-φορμυλ-3-υδροξυφαινυλοξυμεθυλ ενωσεις ικανες ρυθμισης αιμοσφαιρινης
EA201891203A1 (ru) Гетероциклические соединения в качестве иммуномодуляторов
EA201990043A1 (ru) Антибактериальные соединения
BR112017010173A2 (pt) composição para tratamento de tecido
BR112018000632A2 (pt) moléculas de anticorpo que ligam a cd79
EA201491819A1 (ru) Фармацевтические композиции для комбинированного лечения
MX2021008318A (es) Nuevos polipeptidos de union especifica y usos de los mismos.
EA202090683A3 (ru) Способы и композиции для лечения рака
EA201991387A1 (ru) ТРИЦИКЛИЧЕСКИЕ ЕНОНЫ - ПРОИЗВОДНЫЕ ПИРИМИДИНА ДЛЯ ИНГИБИРОВАНИЯ ROR-γ И ДРУГИХ ПРИМЕНЕНИЙ
EA201990400A1 (ru) Соединения и композиции и их применение
EA201692008A1 (ru) Замещенные сконденсированные гетероциклы в качестве модуляторов gpr119 для лечения диабета, ожирения, дислипидемии и связанных нарушений
EA201890449A1 (ru) Фумагиллиновые гетероциклические соединения и способы их получения и применения
CY1124667T1 (el) Τροποποιημενο rna που κωδικοποιει πολυπεπτιδια vegf-a, φαρμακοτεχνικες μορφες, και χρησεις που σχετιζονται με αυτα
ZA202201610B (en) Tobacco leaf extract and use thereof for the treatment of tobacco addiction
EA202090270A1 (ru) Новые замещенные производные ксантина
BR112015028516A2 (pt) tratamento ou prevenção de distúrbios neurodegenerativos com o uso de mentol, linalol e/ou icilina
MA38369A1 (fr) Peptides et compositions pour le traitement d'une lesion de l'articulation
EA202191115A1 (ru) Новые пиридазины
MX2020001256A (es) Compuestos para la prevencion y el tratamiento de trastornos medicos y usos de los mismos.
BR112016019002A2 (pt) composições para a prevenção e/ou o tratamento de patologias associadas a alfa-glicosidase
RO130546A3 (ro) Unguent pentru tratamentul bolii hemoroidale
WO2019022476A3 (ko) 장수애 추출물을 유효성분으로 함유하는 피부 주름 개선 또는 피부 보습용 조성물